Vogelxo
Total Payments
$183,205
Transactions
15
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $183,205 | 15 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $183,205 | 15 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| VOGELXO(R) ABPM STUDY IN HYPOGANDAL MEN | Upsher-Smith Laboratories LLC | $168,899 | 0 |
| A PHASE 4, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE THE EFFECTS OF VOGELXO(R) ON 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING IN HYPOGONADAL MEN USING THERAPEUTIC TESTOSTERONE REPLACEMENT THERAPY | Upsher-Smith Laboratories LLC | $14,306 | 0 |
Top Doctors Receiving Payments for Vogelxo
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Anaheim, CA | $183,205 | 15 |
Ad
Manufacturing Companies
- Upsher-Smith Laboratories LLC $183,205
Product Information
- Type Drug
- Total Payments $183,205
- Total Doctors 0
- Transactions 15
About Vogelxo
Vogelxo is a drug associated with $183,205 in payments to 0 healthcare providers, recorded across 15 transactions in the CMS Open Payments database. The primary manufacturer is Upsher-Smith Laboratories LLC.
Payment data is available from 2022 to 2022. In 2022, $183,205 was paid across 15 transactions to 0 doctors.
The most common payment nature for Vogelxo is "Unspecified" ($183,205, 100.0% of total).
Vogelxo is associated with 2 research studies, including "VOGELXO(R) ABPM STUDY IN HYPOGANDAL MEN" ($168,899).